Jeffrey D. Zigler, J.D.
Jeff Zigler, Director, Health Economics, Reimbursement & Public Policy, has over five years of experience assisting orthopedic and cardiovascular medical device companies achieve reimbursement goals for commercialized products, as well as for those technologies undergoing clinical research. His competencies include health economic outcomes research development and execution; clinical trial agreement development and negotiation, study site selection and reimbursement protocol review; as well as Medicare and commercial carrier repayment management. Jeff also performs coverage and market gap analyses, which are integral to sponsor organizations’ business decision making platforms. Jeff works closely with medical device industry representatives, professional societies and the payor community to advocate for the adoption and appropriate reimbursement of new technologies. Please connect with Jeff on Twitter.
Recent Posts by Jeffrey D. Zigler, J.D.
On February 7, the Centers for Medicare & Medicaid Services (CMS) announced that new data on infection rates in inpatient facilities would inform healthcare utilization decision making by the Agency, via its Hospital Compare program. Information about central line-associated bloodstream infections (CLABSIs) will now be included for assessment of facilities around the nation performing servicesContinue Reading
The Agency for Healthcare Research and Quality (AHRQ) recently posted a notice that it will be soliciting comments until February 21, on the issue of Spinal Fusion for Painful Lumbar Degenerative Disc or Joint Disease. AHRQ wants to understand whether the use of spinal fusion in the treatment of adults with low back pain causedContinue Reading
View the story “CMS Open Door Forum on Prepayment Auditing: Highlights & Key Updates” on Storify]
CMS Requires Medicare Pre-Payment Audits for Cardiovascular and Orthopedic Procedures Effective Jan. 1
The Centers for Medicare & Medicaid Services (CMS) randomly audit health care providers’ claims for reimbursement, to recoup funds the program may have already paid under fraudulent or incorrect pretenses, via Recovery Audit Contractors (RACs). This is part of the broad-sweeping Medicare Claim Review Programs established by the government, processes which were formalized in theContinue Reading